[1] 黄鼎铭,谢彤,崔英,等.20%甘露醇治疗癌性胸水的临床研究(简报)[J]. 广西医科大学学报,2007,24:144-144. [2] 李黄羿,黄鼎铭.特定浓度甘露醇对SPC-A-1人肺癌细胞的凋亡实验研究[J]. 基层医学论坛,2022,26:1-3+7. [3] Liang Q, Gong M, Zou JH, et al. A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma[J]. Drug Resist Updat, 2023;68:100957.doi:10.1016/j.drup.2023.100957. [4] Chiari R, Palladino S, Emili R, et al. KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocar-cinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab[J]. Sci Rep, 2023,13:21036.doi:10.1038/s41598023-48304-0. [5] Gong J, Gu J, Jiang L, et al. Clinical study on the efficacy of bevacizumab in combination with pembrolizu-mab on cellular immune function in the treatment of driver gene-negative stage Ⅳ lung adenocarcinoma[J]. J Oncol, 2022,2022:7298192.doi:10.1155/2022/7298192. [6] Wang Y, Liu C, Chen H, et al. Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma[J]. Signal Transduct Target Ther, 2024,9:153.doi:10.1038/s41392-024-01875-4. [7] Lim SM, Kang SS, Kim DK, et al. Exploration of immune-modulatory effects of amivantamab in combina-tion with pembrolizumab in lung and head and neck squamous cell carcinoma[J]. Cancer Res Commun, 2024,4:1748-1764. [8] Ren K, Peng Q, Ding G, et al. Potential biomarkers and resistance mechanisms of atezolizumab in a patient with lung squamous cell carcinoma[J]. Immunotherapy, 2022,14:15-21. [9] Jiang W, Zhou Y, Zeng L, et al. The efficacy and safety of albumin-bound paclitaxel plus carboplatin as neoad-juvant therapy for potentially resectable lung squamous cell carcinoma: a real-world retrospective cohort study[J]. Transl Lung Cancer Res, 2022,11:647-655. [10] Tang L, Liu J, Zhu L, et al. Curcumin inhibits growth of human NCI-H292 lung squamous cell carcinoma cells by increasing FOXA2 expression[J]. Front Pharmacol, 2018,9:60.doi:10.3389/fphar.2018.00060. [11] 程继,付国,赵华才,等.姜黄素提高人前列腺癌细胞系PC-3放疗敏感性[J]. 基础医学与临床,2021,41:1792-1796. [12] 于振刚,王炳辙,孙开宇.肺鳞癌中Bcl-2、Bax蛋白的表达与细胞凋亡的临床意义[J]. 当代医学,2011,17:10-12. |